Skip to main content

Microbix to Develop Virus Vectors for GE Healthcare Cell Analysis Platforms

NEW YORK, July 26 (GenomeWeb News) - Microbix Biosystems will develop a portfolio of recombinant adenoviruses for use with GE Healthcare's sub-cellular imaging instruments, the company said today.


Under the terms of the agreement, Microbix will develop the vectors for the IN Cell Analyzer 3000 and 1000, which GE Healthcare added to its portfolio following its April acquisition of Amersham. According to an official statement, "a range of ready-to-use assays will be developed to enable researchers to study key cellular events in real time and in a cell line of choice."


Financial terms of the agreement were not disclosed.


The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.